Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cortellaro

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Thrombosis Research|April 1, 1984
A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteersM Cortellaro, C Boschetti, V Antoniazzi, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1992
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study GroupM Cortellaro, C Boschetti, E Cofrancesco, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatmentM Cortellaro, T Nencioni, C Boschetti, et al.
Thrombosis and Haemostasis|August 1, 1994
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT GroupM Cortellaro, E Cofrancesco, C Boschetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 25, 2007
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI studyB Porta, D Baldassarre, M Camera, et al.
Haematologica|May 1, 1990
1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosisP Foa, A T Maiolo, M Cortellaro, et al.
Seminars in Oncology|December 1, 1993
Idarubicin in the therapy of acute myeloid leukemia: final analysis in 57 previously untreated patientsG Lambertenghi Deliliers, C Annaloro, A Oriani, et al.
Haematologica|January 1, 1987
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemiaA T Maiolo, P Foa, M Cortellaro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2009
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatmentD Baldassarre, B Porta, M Camera, et al.
Seminars in Oncology|February 1, 1989
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemiaG Lambertenghi-Deliliers, C Annaloro, A Cortelezzi, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Thrombosis Research|April 1, 1984
A pharmacokinetic and platelet function study of the combined administration of metoprolol and sulfinpyrazone to healthy volunteersM Cortellaro, C Boschetti, V Antoniazzi, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1992
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study GroupM Cortellaro, C Boschetti, E Cofrancesco, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatmentM Cortellaro, T Nencioni, C Boschetti, et al.
Thrombosis and Haemostasis|August 1, 1994
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT GroupM Cortellaro, E Cofrancesco, C Boschetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 25, 2007
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI studyB Porta, D Baldassarre, M Camera, et al.
Haematologica|May 1, 1990
1,25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosisP Foa, A T Maiolo, M Cortellaro, et al.
Seminars in Oncology|December 1, 1993
Idarubicin in the therapy of acute myeloid leukemia: final analysis in 57 previously untreated patientsG Lambertenghi Deliliers, C Annaloro, A Oriani, et al.
Haematologica|January 1, 1987
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemiaA T Maiolo, P Foa, M Cortellaro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 28, 2009
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatmentD Baldassarre, B Porta, M Camera, et al.
Seminars in Oncology|February 1, 1989
Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemiaG Lambertenghi-Deliliers, C Annaloro, A Cortelezzi, et al.
Pageof 9